Profile for Genzyme Cp (GENZ)

Symbol:

Profile for Genzyme Corp. (GENZ)

After Hours: $ 62.59

-2.00 (-3.10%)

Volume: 10.52 k

5:01 PM EDT Oct 10, 2008

Business Description:
A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, diagnostic & predictive testing and cancer.

Address:

500 Kendall Street, Cambridge, MA 02142

Telephone:

(617) 252-7500

Website:

www.genzyme.com

Facsimile:

(617) 252-7600

Email:

Details

CEO:

Henri A. Termeer

Employees:

10000

Market Cap:

17.35 b

Issue Type:

Common Stock

Auditor:

PRICEWATERHOUSECOOPERS LLP

Last Audit:

Unqualified

Indices:

DJ US Biotechnology, Biotechnology, Russell 1000, S&P 1500 Biotechnology Index, S&P 500 Biotechnology Index, S&P 900 Biotechnology Index, S&P Composite

Industry Classifications

Sector:

Healthcare

CIK:

0000732485

Industry:

Drugs

NAICS:

Biological Product (except Diagnostic) Manufacturing (325414)

QM ID:

Biotechnology (515)

SIC:

Biological Products, Except Diagnostic Substances (2836) , Perfumes, Cosmetics, And Other Toilet Preparations (2844) , In Vitro And In Vivo Diagnostic Substances (2835) , Nonclassifiable Establishments (9999)

Profitability

Management Effectiveness

Gross Margin:

78.10

Return on Equity:

6.40

EBIT Margin:

15.90

Return on Capital:

6.30

Profit Margin:

15.70